GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-two research firms that are covering the stock, MarketBeat reports. Ten equities research analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $78.35.
GEHC has been the subject of a number of analyst reports. Barclays raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Wednesday, October 7th. Weiss Ratings raised shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 6th. Royal Bank Of Canada reissued an “outperform” rating on shares of GE HealthCare Technologies in a research report on Monday, October 5th. Citigroup cut their price target on shares of GE HealthCare Technologies from $75.00 to $71.00 and set a “neutral” rating on the stock in a report on Monday, October 5th. Finally, Needham & Company LLC restated a “buy” rating and set a $93.00 price target on shares of GE HealthCare Technologies in a report on Monday, October 5th.
Check Out Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Trading Down 1.1%
Shares of NASDAQ GEHC opened at $69.57 on Thursday. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a market cap of $31.42 billion, a price-to-earnings ratio of 15.96, a P/E/G ratio of 1.84 and a beta of 0.73. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.92. The business has a fifty day simple moving average of $68.54 and a 200-day simple moving average of $66.79.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. The business had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%. GE HealthCare Technologies’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $1.06 EPS. Sell-side analysts predict that GE HealthCare Technologies will post 4.93 EPS for the current year.
GE HealthCare Technologies Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a $0.04 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.21%.
Institutional Trading of GE HealthCare Technologies
Large investors have recently added to or reduced their stakes in the company. Mount Vernon Associates Inc. MD lifted its holdings in shares of GE HealthCare Technologies by 0.8% in the first quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after purchasing an additional 144 shares in the last quarter. Essex Financial Services Inc. grew its holdings in shares of GE HealthCare Technologies by 1.8% during the first quarter. Essex Financial Services Inc. now owns 9,024 shares of the company’s stock valued at $642,000 after buying an additional 156 shares in the last quarter. Brown Lisle Cummings Inc. grew its holdings in shares of GE HealthCare Technologies by 29.3% during the first quarter. Brown Lisle Cummings Inc. now owns 706 shares of the company’s stock valued at $50,000 after buying an additional 160 shares in the last quarter. Beacon Financial Advisory LLC grew its holdings in shares of GE HealthCare Technologies by 5.8% during the first quarter. Beacon Financial Advisory LLC now owns 2,965 shares of the company’s stock valued at $211,000 after buying an additional 162 shares in the last quarter. Finally, Physician Wealth Advisors Inc. grew its holdings in shares of GE HealthCare Technologies by 60.4% during the first quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company’s stock valued at $31,000 after buying an additional 163 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc is a global medical technology and healthcare services company that develops, manufactures and supports products used by hospitals, clinicians and researchers. Its offerings are designed to assist with disease detection, diagnosis, treatment, patient monitoring and clinical workflow management.
The company’s portfolio includes computed tomography, magnetic resonance imaging, X-ray and molecular imaging systems; ultrasound equipment; patient monitoring and anesthesia delivery technologies; and pharmaceutical diagnostics, including contrast agents used in medical imaging.
Recommended Stories
- Five stocks we like better than GE HealthCare Technologies
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
